A Routine Checkup After The Deal Revealed A Much Bigger U.S. Opportunity
Inflexion's three-month review of skincare brand Medik8 moved America to the front of the plan.

Dry Powder: The Private Equity Podcast · Relationships First w/ Inflexion’s Flor KassaiYou can study a company for months before you buy it, but Flor Kassai says you only learn what you really bought once you own it. That is when, in her phrase, you can lift the lid.
Kassai is a managing partner at Inflexion, a private equity firm that buys growing businesses and tries to make them more valuable. Every new acquisition goes through what the firm calls Launchpad, about three months of diagnostic tests across the company.
The point of the checkup is to reorder the growth plan, and in one deal it did exactly that. The United States was one leg of the plan, and the firm reprioritized it and leaned in harder and earlier.
The brand was Medik8, known for science-led skin creams and serums. Inflexion had underwritten a plan to sell more directly to consumers, professionalize a team that was still founder led, and expand digitally, with the United States as one leg of that effort.
Then came Launchpad. The review covers the management team first, comparing its skills with what the plan requires, and then moves through finance, reporting, systems, and sales to see where the company really stands.
For Medik8, the work changed the picture. Kassai said “that the U.S. opportunity was a lot bigger and a lot more interesting than we had originally appreciated.” So Inflexion moved America to the front of the line, and put money and people behind it much earlier than planned.
The firm assembled a strong American team, added resources to the expansion, and made it a priority.
Kassai called Medik8 “a massive success story in the US.”
Inflexion sold Medik8 last year to L'Oreal, the French beauty giant. It kept an investment alongside the buyer, a sign the firm believes there is still more growth to come from the bet its own checkup uncovered.
Questions people ask
What is a value-creation plan in private equity?
It is the operating plan a buyer writes for a company it owns, spelling out how sales, profit, and value will grow. It can include hiring, new products, better systems, expansion into new markets, and changes to pricing or sales.
Why would a firm keep money in a company after selling it?
A seller sometimes reinvests part of its proceeds to keep a smaller stake and share in future gains. Buyers often like it because the former owner still has reason to help, and the seller does it only when it thinks more growth remains.
What does selling direct-to-consumer mean?
It means selling directly to shoppers through a brand's own website and stores, rather than mainly through retailers. For skincare, it can bring higher margins and direct data on what customers want, but it requires strong marketing, fulfillment, and customer service.
